Dry Eye Products Market Report (2020-2027) | The Demand For The Market Will Drastically Increase In The Future
                     Dry Eye Products Market 
Dry Eye Products Market Forecast to 2027 - 
COVID-19 Impact and Global Analysis by 
Product (Antibiotic Drops, Hormone Drops, 
Artificial Tears, and Others); Type 
(Prescription Drugs, and OTC Drugs), and 
Geography
Dry Eye Products Market 
Current and future Market Scenario
 The dry eye product market was valued at US$ 6,385.14 million in 2019 and is projected to reach US$ 9,141.01 million by 
2027; it is expected to grow at a CAGR of 4.8%from 2020 to 2027.
 Dry eye is a chronic syndrome and is a progressive depending upon the cause and severity. It is a condition when a 
person does not have tears to lubricate his or her eyes. Tears are an essential part of maintaining good health of the eye 
and assist in providing good vision. The syndrome is commonly seen among older people and is becoming common 
among people spending a long time in front of the computer. The factors that can cause dry eye include age, 
medications, environmental conditions, long term use of contact lenses. The conditions cannot be cured completely; 
however, it can be managed by using medical products. 
 The dry eye product market growth is mainly attributed to the rising incidences of dry eye and growing older population. 
Moreover, the development of the technology is focusing on stem cell therapy that can help in treating a dry eye 
conditionis further expected to foster the market growthduring the forecast period. However, the side effects caused due 
to eye drops such as blurred vision, increased sensitivity, watering eyes, redness, swelling of eyelids, sticky eyelashes, 
and discomfortlimit the growth of the market.
Key Findings
 The COVID-19 pandemic is perplexing healthcare institutions in North America with unprecedented operational and 
clinical challenges. North American countries such as the US, Canada, and Mexico was totally closed for two to three 
months as the strict lockdown was imposed. The lockdown situation has resulted in a fall down a visit to healthcare 
facilities centers, and fewer prescriptions have been issued for ophthalmic conditions.
 Market Insights
 Rising Incidences of Dry Eye
 The incidence and prevalence of dry eye are rising among all demographics. It is caused by multiple factors that cause 
discomfort, irritation, and visual disturbance. The developed nations are experiencing a significant rise in the 
incidences of dry eye. For instance, in April 2020, according to a study ‘National Health and Wellness Survey’ in the US, 
~16.4 million people were diagnosed with dry eye. The data also stated that the prevalence has gone up by 2.7% 
among the people age 18 to 34 years old. In addition, the prevalence was 18.6% in older people. Based on sex, the 
percentage of prevalence was higher in women; it accounted for 8.8% than men with 4.5%.
Dry Eye Products Market 
 
Market Segments
By Product (Plasma Derived  
Coagulation Factor Concentrates, 
Treatment Type (On-demand, 
Recombinant Coagulation Factor Disease 
Prophylaxis); Therapy 
Concentrates, Desmopressin, (Hemophilia A, Hemophilia B, 
(Replacement Therapy, ITI Therapy, 
Antifibrinolytic Agents) Hemophilia C)
Gene Therapy, Antibody Therapy)
Dry Eye Products Market 
Dominating Segments
 
 Similarly, the incidences of dry eyes are much higher in the European and Asia Pacific regions. Whereas 
  regions like the Middle East and Africa also have increasing prevalence due to the chronic health conditions 
and environmental conditions. According to an article published in 2019 by the Department of Research, King 
Khaled Eye Specialist Hospital, Riyadh, Saudi Arabia, the incidence of dry eye is high among women. The 
primary cause of dry eye was the medication of glaucoma.The increasing incidences of the dry eye lead to 
rising direct cost of treatment. According to Ocular Surgery News, the annual direct cost for mild dry eye 
symptom treatment was US$ 678, for moderate dry eye symptom was US$ 771, and for the severe dry 
symptom was US$ 1,267. Thus, the increasing incidence of the dry eye leads to the growing cost of 
healthcare. And it is also expected to drive the market growth during the forecast period.
 Product-BasedInsights
 Based on product, the dry eye products market is segmented into artificial tears, antibiotic drops, hormone 
drops and others. The artificial tears segment held the largest share of the market in 2019.However, the 
hormone drops segment is anticipated to register the highest CAGR in the market during the forecast period. 
Artificial tear ware widely used for the treatment of the dry eye
Dominating Segments
Product Insights
 These artificial tears help in lubricating and maintaining good moisture on the outer surface of the eye.Many local 
and international players have artificial tears in the product portfolio; for instance, the Refresh product line from 
Allergan Inc. has a dedicated collection to treat dry eye.
 Download PDF Brochure https://www.theinsightpartners.com/sample/TIPRE00012323/ 
 Type-BasedInsights
 Based on type, the dry eye product marketis segmented into OTC Drugs and prescription drugs. The OTC drugs 
segment held the largest share of the market in 2019. However, the prescription drugs segment is anticipated to 
register the highest CAGR in the market during the forecast period.Eye drops which are accessible over the counter 
are also called as non-prescription eye drops. Available at a much lower cost when compared with prescription 
drugs. Eye drops for dry are artificial tears. These drops provide relief from dry eye symptom which are temporary 
in nature. 
Dominating Segments
 Strategic Insights
 Product launches, mergersand acquisitions, collaborations, and expansionsarethe commonly adopted 
strategies by various companies to expand their footprint worldwide and meet the growing demandby 
expanding theirrespective product portfolios.The players operating in the dry eye product marketadopted the 
product innovationsstrategy to cater to changing customer demand worldwide, which also permits them to 
maintain their brand name globally
The report segments the global Dry Eye Products Market as follows:
 
Dry Eye Product Market – byProduct
Artificial Tears
Antibiotic Drops
Hormone Drops
Dominating Segments
Dry Eye Product Market – by Type
OTC Drugs
Prescription Drugs
Dry Eye Products Market  
Leading Players
Company Profiles in Dry Eye Products Market are:
Bayer AG
Sanofi
F. Hoffmann-la Roche Ltd.
Kedrion S.P.A.
CSL Limited
Biotest AG
Pfizer Inc.
Novo Nordisk A/S
Octapharma AG
Baxter International Inc.
  REGIONAL FRAMEWORK
REGIONAL FRAMEWORK
  Dry Eye Products Market  
 
 
 Dry Eye Products Market 
 
        
Access Full Research Report at: 
https://www.theinsightpartners.com/reports/dry-eye-products-market/ 
 
Thank You! 
Thank You!